Woodline Partners LP Day One Biopharmaceuticals, Inc. Transaction History
Woodline Partners LP
- $17.6 Billion
- Q2 2025
A detailed history of Woodline Partners LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 100,516 shares of DAWN stock, worth $617,168. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,516
Previous 213,154
52.84%
Holding current value
$617,168
Previous $1.69 Million
61.36%
% of portfolio
0.0%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding DAWN
# of Institutions
189Shares Held
72.9MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$39.5 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$37.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$27.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$25.2 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$22.9 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $451M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...